Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study

<div>The graph of neurodevelopmental milestones of neonates in two treatment type subgroups intravitreal bevacizumab vs. no treatment in (a) and intravitreal bevacizumab vs. laser in (b).</div>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study 

Figure 2 | Evaluation of Neurodevelopmental Outcomes in Premature Twins (Multigestations) with Retinopathy of Prematurity Receiving Anti-VEGF: A Comparison Study 